miR‐9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC-Reference-Cited by-同舟云学术

miR‐9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC

Published:2021-06 Issue:7 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Citron Francesca¹²^ORCID,Segatto Ilenia¹,Musco Lorena¹,Pellarin Ilenia¹,Rampioni Vinciguerra Gian Luca¹³,Franchin Giovanni⁴,Fanetti Giuseppe⁴,Miccichè Francesco⁵,Giacomarra Vittorio⁶,Lupato Valentina⁶,Favero Andrea¹,Concina Isabella¹,Srinivasan Sanjana²,Avanzo Michele⁷^ORCID,Castiglioni Isabella⁸⁹,Barzan Luigi⁶,Sulfaro Sandro¹⁰,Petrone Gianluigi⁵,Viale Andrea²,Draetta Giulio F²,Vecchione Andrea³,Belletti Barbara¹^ORCID,Baldassarre Gustavo¹^ORCID

Affiliation:

1. Molecular Oncology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCSNational Cancer Institute Aviano Italy

2. Department of Genomic Medicine The University of Texas MD Anderson Cancer Center Houston TX USA

3. Faculty of Medicine and Psychology Department of Clinical and Molecular Medicine University of Rome “Sapienza”Santo Andrea Hospital Rome Italy

4. Oncologic Radiotherapy Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS National Cancer Institute Aviano Italy

5. Università Cattolica del Sacro Cuore Fondazione Policlinico Universitario Agostino Gemelli Polo Scienze Oncologiche ed Ematologiche Rome Italy

6. Division of Otorhinolaryngology Azienda Ospedaliera Santa Maria degli Angeli Pordenone Italy

7. Medical Physics Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS National Cancer Institute Aviano Italy

8. Institute of Molecular Bioimaging and Physiology National Research Council (IBFM‐CNR) Milan Italy

9. Department of Physics Università degli Studi di Milano‐Bicocca Milan Italy

10. Division of Pathology Azienda Ospedaliera Santa Maria degli Angeli Pordenone Italy

Funder

Ministero della Salute

Ministero degli Affari Esteri e della Cooperazione Internazionale

Regione Autonoma Friuli Venezia Giulia

Associazione Italiana per la Ricerca sul Cancro

Fondazione Umberto Veronesi

Fondazione Guido Berlucchi

Cancer Prevention and Research Institute of Texas

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202012872

Reference51 articles.

1. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

2. A miR-centric view of head and neck cancers

3. Current Management of Locally Advanced Head and Neck Cancer: The Combination of Chemotherapy With Locoregional Treatments

4. Sp1 Facilitates DNA Double-Strand Break Repair through a Nontranscriptional Mechanism

5. Sp1 and the ‘hallmarks of cancer’

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear miR-451a activates KDM7A and leads to cetuximab resistance in head and neck squamous cell carcinoma;Cellular and Molecular Life Sciences;2024-06-28

2. Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer;EMBO Molecular Medicine;2024-04-24

3. Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review);Oncology Reports;2024-04-19

4. UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5;Breast Cancer Research;2024-03-11

5. Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma;Signal Transduction and Targeted Therapy;2024-02-12